Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea · Delayed Price · Currency is KRW 1,396,000
+13,000 (0.94%)
At close: Jul 16, 2026
Samsung Biologics Market Cap
Samsung Biologics has a market cap or net worth of 64.62 trillion as of July 17, 2026. Its market cap has decreased by -11.94% in one year.
Market Cap
64.62T
Enterprise Value
64.16T
Revenue
4.81T
Ranking
n/a
PE Ratio
53.38
Stock Price
1,396,000.00
ChartMarket Cap Chart
Since November 10, 2016, Samsung Biologics's market cap has increased from 9.53T to 64.62T, an increase of 578.25%. That is a compound annual growth rate of 21.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 64.62T | -17.64% |
| Dec 30, 2025 | 78.46T | 16.17% |
| Dec 30, 2024 | 67.54T | 24.87% |
| Dec 28, 2023 | 54.09T | -7.43% |
| Dec 29, 2022 | 58.43T | -2.20% |
| Dec 30, 2021 | 59.75T | 9.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 10, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celltrion | 40.32T |
| ALTEOGEN | 14.81T |
| Samsung Epis Holdings | 9.85T |
| SK Biopharmaceuticals | 6.22T |
| Kolon TissueGene | 5.28T |
| HLB Co., Ltd. | 4.69T |
| LigaChem Biosciences | 3.82T |
| D&D Pharmatech | 3.15T |